Results 251 to 260 of about 2,801,899 (401)

Adenosine Receptor Antagonists Including Caffeine Alter Fetal Brain Development in Mice

open access: yesScience Translational Medicine, 2013
Carla G. Silva   +18 more
semanticscholar   +1 more source

Spatiotemporally Controlled Tumor Photodynamic/Immunotherapy Therapy Based on Upconversion Hybrid Nanosystem

open access: yesAdvanced Science, EarlyView.
PURH is constructed by a five‐layer upconversion nanoparticle (UCNP) surface coated with mesoporous silica, which encapsulates rose bengal (RB) within the mesoporous channels. Additionally, CpG oligonucleotides (CpG ODN) is linked to the surface, followed by the surface functionalization of hyaluronic acid (HA). This spatiotemporally controllable smart
Fang Wang   +9 more
wiley   +1 more source

Stimuli‐Responsive Supramolecular Biomaterials for Cancer Theranostics

open access: yesAdvanced Science, EarlyView.
The ultimate goal of cancer theranostics is to get imaging agents and therapeutic cargo to tumor sites when and where they are required. “Smart” systems should be developed. This review discusses the characteristics of physiological stimuli, types and action modes of external stimuli, construction approaches and working principles, as well as ...
Wenting Hu   +4 more
wiley   +1 more source

Inhibition of PAF-induced aggregation of human PMNs and platelets by adenosine: in vitro investigations using a newly developed blood filtration system [PDF]

open access: yes, 1992
Arbogast, Helmut   +7 more
core   +1 more source

DNMT2‐m5C‐ACLY Axis Promotes Lenvatinib Resistance in Hepatocellular Carcinoma Through Histone Acetylation‐Mediated Notch Pathway

open access: yesAdvanced Science, EarlyView.
Lenvatinib resistance poses a major challenge in advanced hepatocellular carcinoma (HCC). This study reveals that DNMT2 upregulation is a key driver, which stabilizes ACLY mRNA via m5C modification and activates the Notch signaling pathway. Crucially, combining ACLY inhibitors with lenvatinib overcomes resistance and suppresses tumors, offering a ...
Shiguang Yang   +14 more
wiley   +1 more source

A<sub>2A</sub> Adenosine Receptor Antagonists and Their Efficacy in Rat Models of Parkinson's Disease. [PDF]

open access: yesCells
Spinaci A   +10 more
europepmc   +1 more source

Caffeine for Prevention of Alzheimer's Disease: Is the A2A Adenosine Receptor Its Target? [PDF]

open access: yesBiomolecules, 2023
Merighi S   +9 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy